Credit: RealPeopleGroup via Getty Images. UK biotech Epsilogen has acquired US-based antibody developer TigaTx in a deal that collates work from the two companies’ alternative antibody isotopes for ...

“Most likely, he’ll play in the VHL or MHL instead.” The main reason? SKA’s front office is refocusing their priorities after a disappointing first-round exit from the KHL playoffs. With the franchise ...

And for those who are wondering: no, he is not coming to Montreal. The Canadiens’ prospect is instead expected to head to the VHL, the equivalent of the American League in Russia. This information was ...

Combined clinical-stage company benefits from a strong pipeline: MOv18 IgE, an anti-Folate Receptorα IgE antibody, currently in a Phase Ib Proof of Concept trial in platinum-resistant ovarian cancer.

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation ...

According to Hockey News Hub on X, the plan appears to be for Zavragin, Pleshkov, and Montreal Canadiens starlet Ivan Demidov to all head to the VHL, Russia's second tier of pro hockey ...

Get Instant Summarized Text (Gist) A clinical trial demonstrated that cord blood-derived natural killer (NK) cells pre-complexed with the bispecific antibody AFM13 showed high efficacy in treating ...

In the rapidly evolving field of antibody drug discovery, the ability to efficiently characterize and screen antibodies and antibody drug conjugates (ADCs) is crucial for developing effective ...

But promising results from a recent clinical trial suggest that broadly neutralizing antibody therapy (bNAbs) may be able to accomplish the next best thing. Data from the trial—a collaboration ...

View Full Profile. Learn about our Editorial Policies. Scientists create monoclonal antibodies by cloning a single antibody-producing cell line. In contrast to polyclonal antibodies, monoclonals are ...